These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 1153843)

  • 21. [Autoradiographic studies of the effect of desmethylimipramine (DMI, Pertofran) on the incorporation of 3H-leucine into the rat brain].
    Gatzke H
    Z Mikrosk Anat Forsch; 1975; 89(6):1118-32. PubMed ID: 1234814
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of chronic desipramine treatment on rat brain adrenergic alpha 2-receptor].
    Sekiya Y; Sugita R; Naitoh H; Kunimi Y; Nomura S
    Yakubutsu Seishin Kodo; 1991 Aug; 11(4):245-55. PubMed ID: 1665932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Relation between the binding of 3H-imipramine and the uptake of catecholamines in synaptosomal preparations of the rat brain after chronic treatment with imipramine].
    Dagonneau H; Fonlupt P; Pacheco H
    C R Seances Soc Biol Fil; 1984; 178(1):38-44. PubMed ID: 6331605
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of neuroleptics on imipramine demethylation in rat liver microsomes and imipramine and desipramine level in the rat brain.
    Daniel W; Melzacka M
    Biochem Pharmacol; 1986 Oct; 35(19):3249-53. PubMed ID: 2876708
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Active metabolites of imipramine and desipramine in man.
    Potter WZ; Calil HM; Sutfin TA; Zavadil AP; Jusko WJ; Rapoport J; Goodwin FK
    Clin Pharmacol Ther; 1982 Mar; 31(3):393-401. PubMed ID: 7060321
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The pharmacokinetics of promazine and its metabolites after acute and chronic administration to rats--a comparison with the pharmacokinetics of imipramine.
    Daniel W; Syrek M; Janczar L; Boksa J
    Pol J Pharmacol; 1995; 47(2):127-36. PubMed ID: 8688885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined effects of desipramine and stress on monoamine turnover in rat brain.
    Naitoh H; Nomura S
    Psychopharmacol Bull; 1990; 26(3):321-6. PubMed ID: 2274631
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Appropriate dosing regimens for treating juvenile rats with desipramine for neuropharmacological and behavioral studies.
    Kozisek ME; Deupree JD; Burke WJ; Bylund DB
    J Neurosci Methods; 2007 Jun; 163(1):83-91. PubMed ID: 17400296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 3H-imipramine and 3H-desipramine binding sites in depression.
    Langer SZ; Raisman R; Sechter D; Gay C; Loo H; Zarifian E
    Adv Biochem Psychopharmacol; 1984; 39():113-25. PubMed ID: 6380221
    [No Abstract]   [Full Text] [Related]  

  • 30. Influence of dose on first-pass kinetics of 14C-imipramine in the isolated perfused rat liver.
    Beaubien AR; Pakuts AP
    Drug Metab Dispos; 1979; 7(1):34-9. PubMed ID: 35324
    [No Abstract]   [Full Text] [Related]  

  • 31. Kinetic properties of the metabolism of imipramine and desipramine in isolated rat hepatocytes.
    Chiba M; Fujita S; Suzuki T
    Biochem Pharmacol; 1990 Jan; 39(2):367-72. PubMed ID: 2302258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Redistribution of tricyclic antidepressants in rats using a drug-specific monoclonal antibody: dose-response relationship.
    Pentel PR; Keyler DE; Brunn GJ; Milavetz JM; Gilbertson DG; Matta SG; Pond SM
    Drug Metab Dispos; 1991; 19(1):24-8. PubMed ID: 1673407
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The in vivo distribution of an antidepressant drug (DMI) in male and female rats.
    Biegon A; Samuel D
    Psychopharmacology (Berl); 1979 Nov; 65(3):259-63. PubMed ID: 117497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sex differences in the uptake and retention of imipramine and desmethylimipramine in the rat lung.
    Ginsburg E; Hirokata Y; Gram TE
    Life Sci; 1982 Mar; 30(9):757-60. PubMed ID: 7070230
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autoradiographic demonstration of binding sites for [3H]desipramine in rat brain.
    Slater P; Crossman AR; Sambrook MA
    Neurosci Lett; 1982 Aug; 31(3):259-63. PubMed ID: 7133561
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetic interaction between imipramine and antidepressant neuroleptics in rats.
    Daniel W
    Pol J Pharmacol Pharm; 1991; 43(3):197-206. PubMed ID: 1683700
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The metabolism of imipramine and its metabolites by rat liver microsomes.
    Bickel MH; Baggiolini M
    Biochem Pharmacol; 1966 Aug; 15(8):1155-69. PubMed ID: 5973159
    [No Abstract]   [Full Text] [Related]  

  • 38. Regulation of CYP3A9 gene expression by estrogen and catalytic studies using cytochrome P450 3A9 expressed in Escherichia coli.
    Wang H; Strobel HW
    Arch Biochem Biophys; 1997 Aug; 344(2):365-72. PubMed ID: 9264551
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiple-dose pharmacokinetics of imipramine and its major active and conjugated metabolites in depressed patients.
    Sutfin TA; Perini GI; Molnar G; Jusko WJ
    J Clin Psychopharmacol; 1988 Feb; 8(1):48-53. PubMed ID: 3350999
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of proadifen, an inhibitor of the metabolism of drugs, on the action of imipramine and desipramine in rats.
    Maj J; Daniel W; Rogóz Z; Skuza G; Sowińska H
    Pol J Pharmacol Pharm; 1981; 33(6):559-67. PubMed ID: 7347808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.